CG2001 is a topical fixed-dose combination formulation containing minoxidil and finasteride, being evaluated for the treatment of male androgenetic alopecia. The trial consisted of the following ...
Centers for Medicare & Medicaid Services (CMS) issues new Healthcare Common Procedure Coding System (HCPCS) codes for Dayspring lower extremity active compression OAKLAND, Calif.--(BUSINESS ...
SEOUL, South Korea, June 8, 2026 /PRNewswire/ -- Dayspring Pharma, a clinical-stage biotechnology company focused on innovative dermatology therapies, announced the first public disclosure of positive ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results